Side effects are rare but may include minor redness or soreness at the injection site
Important note: The effectiveness of sublingual absorption is well documented
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
Compounded preparations of this nature are not subject to the same rigorous quality, safety, and efficacy standards as licensed medicines
If you're noticing initial thinning, early intervention with GHK-Cu may help maintain density
Individuals using GLP-1 medications may experience: Reduced caloric and protein intake Early satiety or nausea Gastrointestinal changes that affect absorption Increased fatigue during metabolic adjustment Because B-complex vitamins support energy metabolism, neurological pathways, and gastrointestinal integrity, supportive supplementation may be considered when intake is reduced or oral tolerance is limited